CHICAGO, Aug. 15, 2019 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is teaming up with internationally-recognized physicians to host an educational conference for people living with sarcoidosis and their loved ones. The event will be taking place at University of Cincinnati's Kresge Auditorium on Sa

NASHUA, N.H., Aug. 15, 2019 /PRNewswire/ -- SPENGA, a workout studio that combines spin, strength and yoga in one 60-minute session, is pleased to announce the opening of its newest location in Nashua, New Hampshire.

MARIETTA, Ga., Aug. 15, 2019 /PRNewswire/ -- SPENGA, a workout studio that combines spin, strength and yoga in one 60-minute session, is pleased to announce the opening of its newest location in East Cobb – Marietta, Georgia.

REDWOOD CITY, Calif., Aug. 15, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that Dr. Pamela Palmer, Chief Medical Officer, will be presenting at the 2

SUNNYVALE, Calif., Aug. 15, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2019.

HOUSTON, Aug. 15, 2019  /PRNewswire/ -- Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced the appointment of Nadia Ag

CLEVELAND, Aug. 15, 2019 /PRNewswire/ -- Let's face it — we all want to age well. Western Reserve Area Agency on Aging (WRAAA) will host its 28th annual AGINGWell Conference & Luncheon: AGEISM-Reframing the Narrative. The event will be held on Wednesday, Aug. 21, 2019, from 8:30 a.m. to 4:30 p.m. at the Holiday Inn i

SILVER SPRING, Md., Aug. 15, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today granted accelerated approval to Rozlytrek (entrectinib), a treatment for adult and adolescent patients whose cancers have the specific genetic defect, NTRK (neurotrophic tyrosine receptor kinase) gene fusion and for whom there are no effective treatments.

SAN FRANCISCO, Aug. 15, 2019 /PRNewswire/ -- MyHealthTeams, creator of the largest and fastest-growing social networks for people facing chronic health conditions, announced today it has

COSTA MESA, Calif., Aug. 15, 2019 /PRNewswire/ -- A recent Gallup poll identified "paying for college" as the #1 financial concern for parents with children under the age of 18.  Student debt levels are at an all-time high and the costs of a college education are outpacing the majority of other household expenses.  Layer in the social pressure parents feel to h